Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biological dosimetry in radiation synovectomy of small finger joints with erbium [169Er] citrate
2006-006380-22Phase 4Completed
- Sponsor
- CIS bio international
- Start
- Dec 2006
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of erbium (169Er) citrate in rheumatoid arthritis (RA) and spondyloarthritis (SpA), sponsored by CIS bio international. Primary endpoint: Dicentric chromosomes in blood lymphocytes. Started Dec 2006; status: completed.
02
Drugs
erbium (169Er) citrate
03
Conditions
rheumatoid arthritis (RA)spondyloarthritis (SpA)
Beyond the preview
Go deeper on 2006-006380-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006380-22.